GV

GV

USD

Visionary Holdings Inc. Common Shares

$1.470+0.030 (2.083%)

Prix en Temps Réel

Consumer Defensive
Education & Training Services
Canada

Graphique des Prix

Loading Chart...

Métriques Clés

Métriques de Marché
Fondamentaux de l'Entreprise
Statistiques de Trading

Métriques de Marché

Ouverture

$1.440

Haut

$1.490

Bas

$1.420

Volume

0.03M

Fondamentaux de l'Entreprise

Capitalisation Boursière

6.0M

Industrie

Education & Training Services

Pays

Canada

Statistiques de Trading

Volume Moyen

1.91M

Bourse

NCM

Devise

USD

Intervalle sur 52 Semaines

Bas $1.022Actuel $1.470Haut $9.6

Actualités Connexes

PR Newswire

Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced that its ...

Voir plus
Visionary Holdings (Nasdaq: GV) Launches Stem Cell-Based Anti-Aging Product Line, Accelerating Expansion into Asia's Premium Regenerative Medicine Market
PR Newswire

Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development

At 10:00 a.m. (Eastern Time, USA) on November 3, 2025, Visionary Holdings Inc. (hereinafter referred to as the "Company", NASDAQ: GV) successfully...

Voir plus
Visionary Holdings Inc. Announces Successful Leadership Transition: Elite Governance Team Leads the Way, Standardized Structure Empowers High-Quality Development
PR Newswire

Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing

Visionary Holdings Inc. (Nasdaq: GV) ("Visionary" or the "Company"), a private education service provider integrating technology and innovation,...

Voir plus
Visionary Holdings Inc. Receives Nasdaq Notification Regarding Delayed Form 20-F Filing
PR Newswire

Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity

Visionary Holdings Inc. ("GV" or the "Company"), a technology-driven multinational enterprise listed on Nasdaq (Nasdaq: GV), today announced the...

Voir plus
Visionary Holdings Launches Toronto-Based Joint Venture to Drive Global Commercialization of Innovative Stem Cell Therapy for Diabetes Remission, Targeting a $150 Billion Market Opportunity